Over time, persistent insomnia and chronic lack of sleep can lead to depression and may predispose you to health complications. Not getting enough sleep is associated with lowered immune system ...
What you might not be aware of is that an estimated 10% to possibly 30% of adults are at some point in time dealing with chronic insomnia. This is far beyond occasional or episodic insomnia.
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
People with this disorder often don’t feel refreshed, which causes them to feel tired, irritable, and unable to concentrate. Insomnia exists in two forms: acute and chronic. Acute insomnia can last ...
These study findings were published in Frontiers in Psychiatry. The first-line treatment option for chronic insomnia is CBT-I, which is typically delivered over 4 to 8 sessions. In March 2020 ...